The company's high P/E ratio relative to its low growth rate...
The company's high P/E ratio relative to its low growth rates could be troubling. Investors seem to be banking on an upturn in business prospects to justify the steep P/E, although continued poor earnings trends could harm the stock price.
Earnings Not Telling The Story For Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SZSE:300534) After Shares Rise 30%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment